UK Hepatitis A, B, C, D, E Diagnostics Market, 2019-2023: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review

The report presents a detailed analysis of the Hepatitis diagnostics market in the UK. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:

     - Hospitals                                                                              
     - Commercial/Private Labs
     - Blood Banks
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.

Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.


Copyright VENTURE PLANNING GROUP
This material is confidential for use by our clients only
and may not be reprinted or reproduced.

VPG Publications, Consulting, Clients www.VPGcorp.com
VPG Market Research Reports www.VPGMarketResearch.com
Partner Reports www.LeadingMarketResearch.com
VENTURE PLANNING GROUP 1271 Avenue of the Americas, Suite 4300 New York, NY 10020
Phone + 1 212 564 2838 Fax + 1 212 564 8133 reports@vpgcorp.com
and List of Tables

I. Introduction
II. Hepatitis Worldwide Market and Technology Overview
A. Background
B. Hepatitis A
C. Hepatitis B
D. Hepatitis C
0 Classification
0 Transmission of Infection
0 Occupational Hazards
0 Acute Hepatitis
0 Diagnosis of Acute Infection
0 Chronic Hepatitis
0 HCV and Other Chronic Liver Diseases
0 Alcoholic Liver Disease
0 Hepatitis B Coinfection
0 Cirrhosis and Hepatocellular Carcinoma
0 Diagnostic Tests
0 Possible Indications for HCV RNA Testing
0 Conclusions and Future Direction
E. Hepatitis D
0 Historical Perspective
0 Epidemiology
0 HBV-HDV "Coinfection" vs. "Superinfection"
0 Methods of Detecting HDV
0 Prevention
F. Hepatitis E
0 Background
0 Prevalence of the Disease
0 Diagnostic Tests
0 Epidemiologic Serosurveys
0 Serologic Cross-Reactivity
G. Hepatitis G
0 Vaccines and Drugs

H. Review of Leading Analyzers Marketed by: Abbott, Beckman
Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche,
Siemens, Tosoh, Wallac and Other Suppliers
I. Emerging Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Other
VIII. U.K.: Market Size, Growth and Major Suppliers
Sales and Market Shares
X. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation

XI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche

- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List Of Tables


Major Companies Developing or Marketing Hepatitis Tests
U.K.
HAV NAT Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
HBV NAT Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
Hbs Ag Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
Hepatitis C Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
Anti-HBc Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
Anti-HBs Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
Anti-HAV Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
Hepatitis Delta Test Volume and Diagnostics Sales
Forecast by Market Segment
U.K.
HBc Ag Test Volume and Diagnostics Sales Forecast
By Market Segment

U.K.
HBe Ag Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
ALT/SGPT Test Volume and Diagnostics Sales Forecast
By Market Segment
U.K.
Hepatitis Testing Market Diagnostics Sales
by Major Supplier
U.K.
Hepatitis C Testing Market Diagnostics Sales
By Major Supplier

2021 UK Transfusion Diagnostics Market Asseessment: Supplier Shares and Sales Segment Forecasts

This report provides an overview of the UK blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening tests, as well

USD 1450 View Report

2021 UK Hematology Instrument and Consumable Market Asseessment: Supplier Shares and Sales Segment Forecasts

This report provides an overview of the U.K. hematology market, including sales and market shares of leading instrument and consumable suppliers, as well as test volume and sales forecasts by

USD 1450 View Report

2021 UK Hepatitis Diagnostics Market Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

This unique report from LeadingMarketResearch.com provides information and analysis not available from any other published source.The report is available by section, and can be customized to specific information needs and

USD 1450 View Report

2024 US Hepatitis A, B, C, D, E Diagnostics Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review, Opportunities for Suppliers

The report presents a detailed analysis of the Hepatitis diagnostics market in the US.The report is available by section, and can be customized to specific information needs and budget.Current scientific

USD 2500 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available